Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Linsitinib | 0.01 | uM | 9 | 2500.00 | 1861.36 | 4358.00 | 4027.75 | 1.0820 | 1.1467 |
| SK-BR-3 | Linsitinib | 0.031623 | uM | 9 | 2500.00 | 1861.36 | 4200.00 | 4027.75 | 1.0428 | 1.0766 |
| SK-BR-3 | Lapatinib | 0.01 | uM | 9 | 2500.00 | 1861.36 | 3302.00 | 4027.75 | 0.8198 | 0.6732 |
| SK-BR-3 | 17-AAG | 0.031623 | uM | 9 | 2500.00 | 1861.36 | 2034.00 | 4027.75 | 0.5050 | 0.0829 |
| SK-BR-3 | Lapatinib | 0.1 | uM | 9 | 2500.00 | 1861.36 | 1915.00 | 4027.75 | 0.4755 | 0.0258 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 9 | 2500.00 | 1861.36 | 4380.00 | 4027.75 | 1.0875 | 1.1564 |
| SK-BR-3 | Linsitinib | 0.31623 | uM | 9 | 2500.00 | 1861.36 | 4061.00 | 4027.75 | 1.0083 | 1.0148 |
| SK-BR-3 | Lapatinib | 0.0016596 | uM | 9 | 2500.00 | 1861.36 | 3960.00 | 4027.75 | 0.9832 | 0.9698 |
| SK-BR-3 | 17-AAG | 0.01 | uM | 9 | 2500.00 | 1861.36 | 2871.00 | 4027.75 | 0.7128 | 0.4757 |
| SK-BR-3 | Lapatinib | 0.031623 | uM | 9 | 2500.00 | 1861.36 | 2418.00 | 4027.75 | 0.6003 | 0.2648 |
| SK-BR-3 | Lapatinib | 0.0033113 | uM | 9 | 2500.00 | 1861.36 | 4017.00 | 4027.75 | 0.9973 | 0.9952 |
| SK-BR-3 | 17-AAG | 0.1 | uM | 9 | 2500.00 | 1861.36 | 1465.00 | 4027.75 | 0.3637 | -0.1935 |
| SK-BR-3 | Linsitinib | 0.0033113 | uM | 9 | 2500.00 | 1861.36 | 4139.00 | 4027.75 | 1.0276 | 1.0495 |
| SK-BR-3 | Linsitinib | 3.1623 | uM | 9 | 2500.00 | 1861.36 | 3557.00 | 4027.75 | 0.8831 | 0.7888 |
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 9 | 2500.00 | 1861.36 | 4241.00 | 4027.75 | 1.0529 | 1.0948 |
| SK-BR-3 | Lapatinib | 1 | uM | 9 | 2500.00 | 1861.36 | 1671.00 | 4027.75 | 0.4149 | -0.0923 |
| SK-BR-3 | 0 | uM | 9 | 2500.00 | 1861.36 | 3813.00 | 4027.75 | 0.9467 | 0.9040 | |
| SK-BR-3 | 0 | uM | 9 | 5000.00 | 3570.27 | 5919.00 | 6344.00 | 0.9330 | 0.8396 | |
| SK-BR-3 | Linsitinib | 0.1 | uM | 9 | 5000.00 | 3570.27 | 5997.00 | 6344.00 | 0.9453 | 0.8689 |
| SK-BR-3 | Lapatinib | 3.1623 | uM | 9 | 5000.00 | 3570.27 | 2900.00 | 6344.00 | 0.4571 | -0.2218 |
| SK-BR-3 | Linsitinib | 10 | uM | 9 | 5000.00 | 3570.27 | 4661.00 | 6344.00 | 0.7347 | 0.3791 |
| SK-BR-3 | Erlotinib | 0.1 | uM | 9 | 5000.00 | 3570.27 | 6226.00 | 6344.00 | 0.9814 | 0.9552 |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 9 | 5000.00 | 3570.27 | 2882.00 | 6344.00 | 0.4543 | -0.2276 |
| SK-BR-3 | Erlotinib | 1 | uM | 9 | 5000.00 | 3570.27 | 6300.00 | 6344.00 | 0.9931 | 0.9833 |
| SK-BR-3 | 17-AAG | 0.0031623 | uM | 9 | 5000.00 | 3570.27 | 6350.00 | 6344.00 | 1.0009 | 1.0023 |